BioSpace News Archive

Zevra Therapeutics, Inc. today announced that R. LaDuane Clifton, the Company’s Chief Financial Officer, will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 3:05 p.m. ET.

Avalyn Pharma Inc. today announced that Lyn Baranowski , CEO, is planning to present a corporate update during the BioEquity Europe conference being held May 14-16, 2023.

G1 Therapeutics, Inc. today presented preliminary results from 30 patients enrolled in its ongoing Phase 2, single arm study of trilaciclib administered prior to the antibody-drug conjugate (ADC), sacituzumab govitecan-hziy in patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC).

Korro Bio, a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Shelby Walker, JD, as Senior Vice President and General Counsel.

Syros Pharmaceuticals today reported financial results for the quarter ended March 31, 2023 and provided a corporate update.

KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer.

FSD Pharma Inc. today announced the completion of dosing the first cohort of patients in the Company’s Phase I clinical trial of Lucid-21-302 (“Lucid-MS”).

Sonnet BioTherapeutics Holdings, Inc. announced today its financial results for the three months and six months ended March 31, 2023 and provided a business update.

Capsida Biotherapeutics (“Capsida”) today announced it will present preliminary data on the company’s next-generation engineered adeno-associated virus (AAV) capsids in non-human primates.

ImmPACT Bio USA , Inc. today announced that it will participate at the 2023 RBC Capital Markets Global Healthcare Conference, to be held from May 16-17, 2023.